undamentalytics Newsletter
Sign in

Mindwalk Holdings Corp. revenue

Mindwalk Holdings Corp.'s revenue was $11.3m in fiscal 2026, up 47.8% on the year before. Since fiscal 2020 ($10.5m) it has grown at a compound 1.2% a year.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2020Apr 20202021Apr 20212022Apr 20222023Apr 20232024Apr 20242025Apr 20252026Apr 2026
Revenue111415168811
Growth on the year before—+30.2%+12.7%+0.7%−51.0%+0.2%+47.8%
Gross profit6999347
Gross margin57.1%64.4%56.7%56.0%39.8%53.9%58.8%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Revenue against peers

Biotechnology: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Mindwalk Holdings Corp. $11.3m 47.8% —
Surrozen, Inc. $11.5m -8.8% —
Relay Therapeutics, Inc. $10.3m 23.9% 122.3%
Caribou Biosciences, Inc. $10.0m 10.0% -11.0%
Opus Genetics, Inc. $9.9m -36.1% -39.8%
Lineage Cell Therapeutics, Inc. $13.1m 19.9% 7.5%

Compare with peers

Head to head: HYFT vs SRZNHYFT vs RLAYCRBU vs HYFTHYFT vs IRD

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Mindwalk Holdings Corp.'s SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Mindwalk Holdings Corp.